September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Topical delivery of NT4 promotes retinal ganglion cell survival following neuronal injury in Thy1.YFP mice
Author Affiliations & Notes
  • Chendong Pan
    Weil Cornell Medicine, New York, New York, United States
  • Anna M Demetriades
    Weil Cornell Medicine, New York, New York, United States
  • Footnotes
    Commercial Relationships   Chendong Pan, None; Anna Demetriades, None
  • Footnotes
    Support  BrightFocus Foundation National Glaucoma Research Grant; Research to Prevent Blindness Career Development Award
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5638. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Chendong Pan, Anna M Demetriades; Topical delivery of NT4 promotes retinal ganglion cell survival following neuronal injury in Thy1.YFP mice. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5638.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Neurotrophin-4 (NT4) is a neurotrophic factor that regulates the survival, differentiation and mature function of neurons. This study aims to determine if topical delivery of NT4 promotes retinal ganglion cell survival in a murine model of optic nerve crush injury.

Methods : Adult Thy1.YFP mice, which express yellow fluorescent protein as a marker of viable retinal neurons, were used for the purpose of this study. At the time of optic nerve crush injury, an ophthalmic gel-forming solution containing purified NT4 (10µg/µl) was applied to the eye on a daily basis. Micron III fundus imaging was performed to quantify in vivo retinal ganglion cell fluorescence during this time. Mice were sacrificed at four days and retinal flat mounts prepared. ELISA was performed to quantify NT4 levels in the retina and optic nerve of treated eyes.

Results : Topical delivery of NT4 resulted in increased NT4 levels (ng/mg protein) in the retina compared to untreated eyes (2.4 vs 0.01) and optic nerve (105.2 vs 0.1) (n=5). Micron III image fluorescence analysis demonstrated that the majority of RGC loss (78% fluorescence peak loss) occurred within the first four days of optic nerve crush injury. A reduction in RGC loss (49% fluorescence peak loss) was observed following topical delivery of NT4 at four days. In retinal flatmounts, the number of fluorescent cells in untreated eyes without optic nerve crush injury was 3213±95 cells/mm3. At four days following optic nerve crush injury, NT4 treated eyes (2153± 174, n=8) showed significantly more remaining fluorescent cells than untreated eyes (1496±82, n=4) (p<0.0001).

Conclusions : Topical delivery of NT4 results in increased NT4 levels in the retina and optic nerve leading to protection of retinal neurons following optic nerve crush injury in Thy1-YFP mice. Fluorescent cells predominantly represent retinal ganglion cells in this model; therefore these findings suggest that topical NT4 provides a neuroprotective effect on retinal ganglion cells in the immediate period following optic nerve injury.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×